David Borg

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 6

Top Topics

Locally Advanced

Epidermal Growth Factor Receptor

Neoadjuvant Chemotherapy

Top Venues

BMC clinical pathology

Journal of clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Cathy E Richards, Katherine M Sheehan, Elaine W Kay, Charlotta Hedner, David Borg, Joanna Fay, Anthony O'Grady, Arnold D K Hill, Karin Jirström, Ann M Hopkins
Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers. Cancers 13 (6) (2021)
Maria Christina Svensson, Albin Lindén, Jakob Nygaard, David Borg, Charlotta Hedner, Björn Nodin, Karin Leandersson, Karin Jirström
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival. Oncoimmunology 10 (1) (2021)
David Borg, Jan Sundberg, Eva Brun, Elisabeth Kjellén, Kristoffer Petersson, Michael Hermansson, Jan Johansson, Jakob Eberhard, Anders Johnsson
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial. Acta oncologica (Stockholm, Sweden) 59 (2) (2019)
David Borg, Anna H Larsson, Charlotta Hedner, Björn Nodin, Anders Johnsson, Karin Jirström
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma. Journal of translational medicine 16 (1) (2018)
Charlotta Hedner, David Borg, Björn Nodin, Emelie Karnevi, Karin Jirström, Jakob Eberhard
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment. Journal of clinical pathology 71 (5) (2017)
David Borg, Charlotta Hedner, Björn Nodin, Anna Larsson, Anders Johnsson, Jakob Eberhard, Karin Jirström
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma. BMC clinical pathology 16 (2016)